Imagine walking into a health care clinic only to find that our loved one cannot receive the medication their doctor recommends, not because it is unsafe or unproven, but because their insurance requires them to “fail first.” This practice, known as step therapy, forces patients to try cheaper medications before gaining access to the treatments their physicians know are most effective. In theory, it is meant to control costs. In reality, it delays care, worsens disease outcomes, and undermines medical judgment.
Step therapy places bureaucracy above medicine. It compels patients to take medications that may be ineffective or even harmful, prolonging suffering and increasing the risk of irreversible complications. Worse still, protections against this practice are inconsistent across states and insurance types. As a result, many of us face uncertainty each time we switch jobs, plans, or providers, never knowing whether we will be forced to “fail first” again.
The solution lies in passing the Safe Step Act, a bipartisan bill currently pending in both the United States Senate and the House of Representatives. The act would create a standardized process for step therapy exceptions nationwide, allowing physicians to override fail-first requirements when medically appropriate. Through this reform, patients would gain faster access to the treatments they need, doctors would face fewer administrative burdens, and insurers would ultimately save money by treating illnesses correctly the first time.
This reform is not just practical; it is urgent. According to the Patient Access Network Foundation (2024), one in six adults in the United States reports being forced by insurance to try and fail on a cheaper medication before obtaining an effective one. Even more troubling, one in five of these patients ends up in the emergency room or hospitalized as a direct result. The American Medical Association (2024) has found that prior authorization and step therapy delay necessary care 94 percent of the time, lead to hospitalization in 19 percent of cases, cause serious adverse events in 13 percent, and even result in permanent disability, birth defects, or death in 7 percent. These are not abstract statistics. They represent real people whose lives are endangered by policies that prioritize savings over safety.
Consider Sofia, a woman living with severe psoriasis, psoriatic arthritis, and a rare form of blood cancer. After years of pain, her doctors found a medication that controlled her skin and joint disease without worsening her cancer. She finally returned to work and regained her quality of life.
But when she changed insurance plans, her new insurer refused to cover the medication that had restored her health. Instead, they forced her to retry a drug that had already failed. For six months, Sofia endured excruciating pain, sleepless nights, and social isolation. The damage she experienced could have been entirely prevented. Her story is one of many that show why reform cannot wait.
If we do nothing, the consequences will deepen. More patients will suffer unnecessary harm, healthcare costs will continue to rise due to preventable hospitalizations, and trust in our healthcare system will erode further. Patients should never be collateral damage in a cost-saving experiment.
But if we act now and pass the Safe Step Act, the outcome will be transformative. Patients will gain consistent protections across all states and insurance plans, ensuring they receive the treatments their doctors prescribe without unnecessary obstacles. Physicians will regain autonomy to make decisions in the best interests of their patients, reducing moral distress and burnout. Employers and insurers will benefit as well. When patients receive effective treatment early, they stay healthier, miss fewer workdays, and require fewer hospital visits. Preventing disease progression is not only humane; it is economically wise.
The path forward requires unity. We, as physicians, patients, advocates, and citizens, must raise our voices together and send a clear message that every patient deserves timely, effective care, free from arbitrary barriers. This is more than a policy debate; it is a moral imperative. Passing the Safe Step Act will protect people like Sofia, ensure that future generations receive the care they need, and reaffirm that compassion, not cost-cutting, belongs at the heart of American medicine.
We cannot allow suffering to continue when the solution is already within reach. It is time for us to act, to speak, and to demand that Congress pass the Safe Step Act so that no one has to endure preventable pain while waiting to “fail first.”
Ali Asghar Kassamali is a senior at Johns Hopkins University, where he majors in Natural Sciences. His research has been featured in scientific and medical publications across the United States. He writes from Baltimore.
